跳至主要内容
临床试验/EUCTR2007-000354-31-IT
EUCTR2007-000354-31-IT
进行中(未招募)
不适用

A randomized trial investigating the role of FOLFOX-4 regimen duration (3 versus 6 months) and bevacizumab as adjuvant therapy for patients with stage II/III colon cancer - 3 months vs 6 months FOLFOX-4

GISCAD0 个研究点2007年11月22日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
未指定
发起方
GISCAD
状态
进行中(未招募)
最后更新
14年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2007年11月22日
结束日期
待定
最后更新
14年前
研究类型
Interventional clinical trial of medicinal product
性别
All

研究者

发起方
GISCAD

入排标准

入选标准

  •  Histologically confirmed AJCC/UICC high\-risk stage II or stage III colon cancer .
  •  Age \>18 years
  •  Curative surgery no less than 3 and no more than 8 weeks prior to randomization
  •  ECOG performance Status (ECOG\-PS) \<1
  •  Signed written informed consent obtained prior to any study specific procedures
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes

排除标准

  •  Macroscopic or microscopic evidence of residual tumor
  •  Previous anti\-angiogenic treatment for any malignancy; cytotoxic chemotherapy, radiotherapy or immunotherapy for colon cancer
  •  Other malignancies within the last 5 years
  •  Lactating women
  •  Fertile women not willing to use effective means of contraception
  •  History of clinically relevant psychiatric disability , precluding informed consent
  •  Clinically relevant cardiovascular disease
  •  Current or recent (within the 28 days prior to randomization) treatment with another investigational drug or participation in another investigational study

结局指标

主要结局

未指定

相似试验

进行中(未招募)
1 期
A randomized investigation of side effects to FOLFOXIRI in combination with tocotrienol or placebo as first line treatment of metastatic colorectal cancer.
EUCTR2015-004850-17-DKVejle Hospital70
进行中(未招募)
不适用
Randomized controlled trial of the efficacy of fosfomycin vs ciprofloxacin as antibiotic prophylaxis before transrectal ultrasound guided prostateurinary sepsisTherapeutic area: Body processes [G] - Microbiological Phenomena [G06]
EUCTR2012-001031-31-ESFundación para Formación e Investigación Sanitaria
已完成
不适用
A randomised controlled trial of the use of the Foley catheter balloon for induction of labour to reduce the incidence of caesarean section in diabetic pregnancies: a prospective clinical, economic and psychological evaluatioPregnancy and Childbirth: Labour inductionPregnancy and ChildbirthLabour induction
ISRCTN39708525Record Provided by the NHSTCT Register - 2007 Update - Department of Health80
进行中(未招募)
1 期
Randomisierte Studie zur Wirksamkeit von FOLFIRI in Kombination mit Cetuximab vs. Bevacizumab in der Erstlinien-Behandlung des metastasierten kolorektalen KarzinomsEnglish translation:Randomised study for efficiency of FOLFIRI in combination with Cetuximab vs. Bevacizumab in first-line-therapy of metastatic colorectal cancer - FIRE-3Metastatic colorectal cancerMedDRA version: 20.0Level: LLTClassification code 10052362Term: Metastatic colorectal cancerSystem Organ Class: 100000016864
EUCTR2006-004030-32-DEKlinikum der Ludwig-Maximilians Universität München, Klinikum Großhadern800
已完成
不适用
A randomised controlled trial of the effects of fruit intake on cardiovascular disease risk factors in childreCardiovascular disease risk factors in childrenDiet and Nutrition - ObesityCardiovascular - Coronary heart diseasePublic Health - Health promotion/education
ACTRN12613001280796Monash University250